FormDSignal
30

Toggle Bio raises $200K in first capital round under Reg D 506(b)

Company raise · Closed · DURHAM, NC · Form D filed 2026-10-06

Toggle Bio, a Delaware biotech corporation incorporated in 2026, raised $200K from 14 investors in its first offering under Regulation D exemption 506(b). The Durham, NC-based company closed the offering on its first sale date of May 2, 2026, with a $5K minimum investment.

Note: First raise on EDGAR; company incorporated in 2026, same year as filing. No placement agent listed despite 14 investors acquired.

First raise on EDGARother

Why now — by persona

  • Executive & technical recruiting:A concrete reason to call this issuer this week, citing the filing. Subscribe to unlock
  • B2B software & services sales:A concrete reason to call this issuer this week, citing the filing. Subscribe to unlock
  • Commercial banking / treasury:A concrete reason to call this issuer this week, citing the filing. Subscribe to unlock
  • D&O and management-liability insurance:A concrete reason to call this issuer this week, citing the filing. Subscribe to unlock
  • Outsourced accounting / CFO:A concrete reason to call this issuer this week, citing the filing. Subscribe to unlock

People on the filing

Craig D LaBodaExecutive Officer, Director
Nicholas K PinkinExecutive Officer, Director
Sean M BurrowsExecutive Officer, Director

Signed by Craig LaBoda, CEO.

Filing contact

The issuer's phone number and address from the filing are shown to subscribers. See plans, or read it on EDGAR.